Aura Biosciences, Inc. (AURA) Financials

AURA Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 348.1 million 32.9 million
March 31, 2026 137.7 million 30.4 million
Dec. 31, 2025 169.4 million 32.5 million
Sept. 30, 2025 190.0 million 33.4 million

AURA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -31.8 million 12.4 million
March 31, 2026 -30.0 million 3.8 million
Dec. 31, 2025 -20.6 million 3.3 million
Sept. 30, 2025 -20.2 million 3.7 million

AURA Net Income

No data available :(

AURA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 323.8 million - 16.6 million
March 31, 2026 114.7 million 13.7 million 3.3 million
Dec. 31, 2025 144.2 million 14.1 million 3.2 million
Sept. 30, 2025 161.9 million - 17.8 million

AURA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 94.9 million
March 31, 2026 67.4 million
Dec. 31, 2025 60.3 million
Sept. 30, 2025 65.9 million

AURA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 21000 30.7 million 17.3 million -
March 31, 2026 102000 28.0 million 6.9 million -
Dec. 31, 2025 176000 21.9 million 5.3 million -
Sept. 30, 2025 45000 22.2 million 5.7 million -

AURA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 274000
Dec. 31, 2025 - -600000
Sept. 30, 2025 - 300000

AURA

Price: $6.28

52 week price:
4.73
9.54

Earnings Per Share: -1.73 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 120900

Market Capitalization: 661.0 million

Links: